Composite Biomarker Helps ID Early-Stage Pancreatic Ductal Adenocarcinoma

FRIDAY, Sept. 18, 2026-- A composite biomarker may complement existing strategies for the detection of early-stage pancreatic ductal adenocarcinoma (PDAC), according to a study published online Sept. 16 in Nature Medicine.Caiming Xu, M.D., Ph.D...